Ginkgo Bioworks (DNA) Reports In-Line Q1 EPS, misses on revenue

Ginkgo Bioworks (NYSE: DNA) reported Q1 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $37.94 million versus the consensus estimate of $46.37 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Rubrik (RBRK) Tops Q2 EPS by 16c, Beats on Revenue; Offers FY27 EPS Guidance
• HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance